Acasti raises $10M in follow-on

Metabolic company Acasti Pharma Inc. (TSX-V:ACST; NASDAQ:ACST) said on Dec. 27, 2017, it raised $10 million in a follow-on underwritten by Benchmark and Dawson James Securities. The offering comprise...